Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Osteoblastic N-cadherin is not required for microenvironmental support and regulation of hematopoietic stem and progenitor cells.

Bromberg O, Frisch BJ, Weber JM, Porter RL, Civitelli R, Calvi LM.

Blood. 2012 Jul 12;120(2):303-13. doi: 10.1182/blood-2011-09-377853. Epub 2012 May 17.

2.

N-cadherin in osteolineage cells is not required for maintenance of hematopoietic stem cells.

Greenbaum AM, Revollo LD, Woloszynek JR, Civitelli R, Link DC.

Blood. 2012 Jul 12;120(2):295-302. doi: 10.1182/blood-2011-09-377457. Epub 2012 Feb 9.

3.

Osteoblastic expansion induced by parathyroid hormone receptor signaling in murine osteocytes is not sufficient to increase hematopoietic stem cells.

Calvi LM, Bromberg O, Rhee Y, Weber JM, Smith JN, Basil MJ, Frisch BJ, Bellido T.

Blood. 2012 Mar 15;119(11):2489-99. doi: 10.1182/blood-2011-06-360933. Epub 2012 Jan 18.

4.

Lack of evidence that hematopoietic stem cells depend on N-cadherin-mediated adhesion to osteoblasts for their maintenance.

Kiel MJ, Radice GL, Morrison SJ.

Cell Stem Cell. 2007 Aug 16;1(2):204-17. doi: 10.1016/j.stem.2007.06.001.

5.

Hematopoietic stem cells do not depend on N-cadherin to regulate their maintenance.

Kiel MJ, Acar M, Radice GL, Morrison SJ.

Cell Stem Cell. 2009 Feb 6;4(2):170-9. doi: 10.1016/j.stem.2008.10.005.

6.

In vivo prostaglandin E2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cells.

Frisch BJ, Porter RL, Gigliotti BJ, Olm-Shipman AJ, Weber JM, O'Keefe RJ, Jordan CT, Calvi LM.

Blood. 2009 Nov 5;114(19):4054-63. doi: 10.1182/blood-2009-03-205823. Epub 2009 Sep 2.

7.

Strontium can increase some osteoblasts without increasing hematopoietic stem cells.

Lymperi S, Horwood N, Marley S, Gordon MY, Cope AP, Dazzi F.

Blood. 2008 Feb 1;111(3):1173-81. Epub 2007 Oct 30.

8.

The role of parathyroid hormone and insulin-like growth factors in hematopoietic niches: physiology and pharmacology.

Garrett RW, Emerson SG.

Mol Cell Endocrinol. 2008 Jun 25;288(1-2):6-10. doi: 10.1016/j.mce.2008.02.022. Epub 2008 Mar 2. Review.

PMID:
18400373
9.

Parathyroid hormone enhances hematopoietic expansion via upregulation of cadherin-11 in bone marrow mesenchymal stromal cells.

Yao H, Miura Y, Yoshioka S, Miura M, Hayashi Y, Tamura A, Iwasa M, Sato A, Hishita T, Higashi Y, Kaneko H, Ashihara E, Ichinohe T, Hirai H, Maekawa T.

Stem Cells. 2014 Aug;32(8):2245-55. doi: 10.1002/stem.1701.

10.

N-cadherin expression level distinguishes reserved versus primed states of hematopoietic stem cells.

Haug JS, He XC, Grindley JC, Wunderlich JP, Gaudenz K, Ross JT, Paulson A, Wagner KP, Xie Y, Zhu R, Yin T, Perry JM, Hembree MJ, Redenbaugh EP, Radice GL, Seidel C, Li L.

Cell Stem Cell. 2008 Apr 10;2(4):367-79. doi: 10.1016/j.stem.2008.01.017.

11.

Role of N-cadherin in the regulation of hematopoietic stem cells in the bone marrow niche.

Arai F, Hosokawa K, Toyama H, Matsumoto Y, Suda T.

Ann N Y Acad Sci. 2012 Aug;1266:72-7. doi: 10.1111/j.1749-6632.2012.06576.x.

PMID:
22901259
12.

N-cadherin restrains PTH activation of Lrp6/β-catenin signaling and osteoanabolic action.

Revollo L, Kading J, Jeong SY, Li J, Salazar V, Mbalaviele G, Civitelli R.

J Bone Miner Res. 2015 Feb;30(2):274-85. doi: 10.1002/jbmr.2323.

13.

Osteoblastic activation in the hematopoietic stem cell niche.

Calvi LM.

Ann N Y Acad Sci. 2006 Apr;1068:477-88. Review.

PMID:
16831945
14.

The effects of zoledronic acid in the bone and vasculature support of hematopoietic stem cell niches.

Soki FN, Li X, Berry J, Koh A, Sinder BP, Qian X, Kozloff KM, Taichman RS, McCauley LK.

J Cell Biochem. 2013 Jan;114(1):67-78. doi: 10.1002/jcb.24301.

15.

Knockdown of N-cadherin suppresses the long-term engraftment of hematopoietic stem cells.

Hosokawa K, Arai F, Yoshihara H, Iwasaki H, Nakamura Y, Gomei Y, Suda T.

Blood. 2010 Jul 29;116(4):554-63. doi: 10.1182/blood-2009-05-224857. Epub 2010 Apr 28.

16.

Proteoglycan 4, a novel immunomodulatory factor, regulates parathyroid hormone actions on hematopoietic cells.

Novince CM, Koh AJ, Michalski MN, Marchesan JT, Wang J, Jung Y, Berry JE, Eber MR, Rosol TJ, Taichman RS, McCauley LK.

Am J Pathol. 2011 Nov;179(5):2431-42. doi: 10.1016/j.ajpath.2011.07.032. Epub 2011 Sep 21.

17.

Increased mobilization of c-kit+ Sca-1+ Lin- (KSL) cells and colony-forming units in spleen (CFU-S) following de novo formation of a stem cell niche depends on dynamic, but not stable, membranous ossification.

Nagayoshi K, Ohkawa H, Yorozu K, Higuchi M, Higashi S, Kubota N, Fukui H, Imai N, Gojo S, Hata J, Kobayashi Y, Umezawa A.

J Cell Physiol. 2006 Jul;208(1):188-94.

PMID:
16575918
18.

Disruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH.

Li C, Xing Q, Yu B, Xie H, Wang W, Shi C, Crane JL, Cao X, Wan M.

J Bone Miner Res. 2013 Oct;28(10):2094-108. doi: 10.1002/jbmr.1962.

19.

Bone, microenvironment and hematopoiesis.

Shen Y, Nilsson SK.

Curr Opin Hematol. 2012 Jul;19(4):250-5. doi: 10.1097/MOH.0b013e328353c714. Review.

PMID:
22504524
20.

N-cadherin restrains PTH repressive effects on sclerostin/SOST by regulating LRP6-PTH1R interaction.

Yang H, Dong J, Xiong W, Fang Z, Guan H, Li F.

Ann N Y Acad Sci. 2016 Dec;1385(1):41-52. doi: 10.1111/nyas.13221. Epub 2016 Oct 10.

PMID:
27723935

Supplemental Content

Support Center